Using ChEMBL to Complement Schistosome Drug Discovery
Schistosomiasis is one of the most important neglected tropical diseases. Until an effective vaccine is registered for use, the cornerstone of schistosomiasis control remains chemotherapy with praziquantel. The sustainability of this strategy is at substantial risk due to the possibility of praziqua...
Saved in:
Main Authors: | Gilda Padalino (Author), Avril Coghlan (Author), Giampaolo Pagliuca (Author), Josephine E. Forde-Thomas (Author), Matthew Berriman (Author), Karl F. Hoffmann (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quorum sensing N-Acyl homoserine lactones are a new class of anti-schistosomal.
by: Helen Whiteland, et al.
Published: (2020) -
The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets.
by: Kezia C L Whatley, et al.
Published: (2019) -
Anti-schistosomal intervention targets identified by lifecycle transcriptomic analyses.
by: Jennifer M Fitzpatrick, et al.
Published: (2009) -
Establishing transgenic schistosomes.
by: Victoria H Mann, et al.
Published: (2011) -
Schistosoma mansoni Larval Extracellular Vesicle protein 1 (SmLEV1) is an immunogenic antigen found in EVs released from pre-acetabular glands of invading cercariae.
by: Thomas A Gasan, et al.
Published: (2021)